ERBB2 and breast carcinoma: To investigate whether inhibition of HER2 and STAT3 sensitizes HER2-positive SKBR3 breast cancer cells to irradiation, we used chemical inhibitors, lapatinib and S3I-201, that target HER2 and STAT3, respectively.